Ligand Pharmaceuticals | LGND - Les Intérêts Débiteurs Sur La Dette





Les Intérêts Débiteurs Sur La Dette Changement Date
Agenus USD 16.02M 2.85M 2025-12
Amgen USD 657M 4M 2026-03
Anika Therapeutics 179.39M 556.84M 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Baxter International USD 58M 14M 2025-09
Bristol-Myers Squibb USD 411M 21M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Enanta Pharmaceuticals USD 1.96M 620K 2024-12
Enviri Corporation USD 28.44M 1.74M 2025-12
Gilead Sciences USD 240M 15M 2026-03
GlaxoSmithKline GBP 167M 21M 2026-03
Glaxosmithkline GBP 192.73M 14.79M 2026-03
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.08M 517K 2026-03
Intrexon USD 2K 5K 2024-06
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Karyopharm Therapeutics USD 12.62M 1.24M 2025-12
Ligand Pharmaceuticals USD 1.78M 875K 2025-12
MacroGenics USD 4.89M 1.55M 2026-03
Merck USD 479M 67M 2026-03
Pacira USD 3.7M 193K 2026-03
Pfizer USD 671M 40M 2026-03
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Veracyte USD 2K 1000 2023-12